Baiyang Pharmaceutical (301015.SZ) announced that Beijing Baiyang Zhihe Medical Achievement Transformation Service Co., Ltd., a wholly-owned subsidiary of the company...
Zhitong Finance App News, Baiyang Pharmaceutical (301015.SZ) announced that Beijing Baiyang Zhihe Medical Achievement Transformation Service Co., Ltd. (“Baiyang Zhihe”), a wholly-owned subsidiary of the company, intends to transfer 100% of its shares in Beijing Baiyang Zhixin Medical Research Co., Ltd. (“Beijing Baiyang Zhixin”) to Baiyang Group at a price of 10 million yuan.
In addition, Beijing Baiyang Guosheng Medical Devices Co., Ltd. (“Baiyang Guosheng” for short), a holding subsidiary of the company, plans to transfer 57% of its shares in Qingdao Baiyang Dacheng Medical Equipment Co., Ltd. (“Baiyang Dacheng”) to Baiyang Group at a price of 5.9257 million yuan. Baiyang Guosheng plans to transfer 35% of its shares in Beijing Huake Pioneer Medical Devices Co., Ltd. (“Huake Pioneer”) to Baiyang Group at a price of 35 million yuan.
According to the announcement, Beijing Baiyang Zhixin, Baiyang Dacheng, and Huake Pioneer are all currently in the start-up investment stage due to their short establishment time and long product development cycle, and their operations are all at a loss. This transfer of shares in the target company can reduce the company's operating risks and enhance the company's profitability. After the transaction was completed, Beijing Baiyang Zhixin and Baiyang Dahian were no longer included in the company's consolidated statements.